Biotika AS 2015 AR2
The report outlines the financial and operational performance of Biotika a.s. for the fiscal year 2015. The company achieved a profit before tax of EUR 5.45 million, driven by strong sales of active pharmaceutical ingredients, particularly Product H. Environmental initiatives, managed by its subsidiary COV a.s., focused on wastewater treatment, waste management, and biogas production, resulting in a 92.46% waste recovery rate. Additionally, Biotika maintained a stable workforce of 417 employees and successfully passed an FDA audit for GMP compliance.
Company: Biotika AS
Sector: Manufacturing
Country: Slovakia
Year: 2015
Type: AR2
Pages: 100
Back to company
Biotika AS
Annual Report
The report outlines the financial and operational performance of Biotika a.s. for the fiscal year 2015. The company achieved a profit before tax of EUR 5.45 million, driven by strong sales of active pharmaceutical ingredients, particularly Product H. Environmental initiatives, managed by its subsidiary COV a.s., focused on wastewater treatment, waste management, and biogas production, resulting in a 92.46% waste recovery rate. Additionally, Biotika maintained a stable workforce of 417 employees and successfully passed an FDA audit for GMP compliance.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2015
Reporting Period
Jan 1, 2015 - Dec 31, 2015
Fiscal Year
2015
Type
Annual Report with Sustainability Disclosures
Language
English, Slovak
Pages
File Size
Standards & Assurance
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Total Waste
Employees